Buckner JH - Search Results

1

Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function.

Long SA, Rieck M, Sanda S, Bollyky JB, Samuels PL, Goland R, Ahmann A, Rabinovitch A, Aggarwal S, Phippard D, Turka LA, Ehlers MR, Bianchine PJ, Boyle KD, Adah SA, Bluestone JA, Buckner JH, Greenbaum CJ; Diabetes TrialNet and the Immune Tolerance Network. Long SA, et al. Among authors: buckner jh. Diabetes. 2012 Sep;61(9):2340-8. doi: 10.2337/db12-0049. Epub 2012 Jun 20. Diabetes. 2012. PMID: 22721971 Free PMC article. Clinical Trial.

2

Optimization of human T-cell expansion ex vivo using magnetic beads conjugated with anti-CD3 and Anti-CD28 antibodies.

Kalamasz D, Long SA, Taniguchi R, Buckner JH, Berenson RJ, Bonyhadi M. Kalamasz D, et al. Among authors: buckner jh. J Immunother. 2004 Sep-Oct;27(5):405-18. doi: 10.1097/00002371-200409000-00010. J Immunother. 2004. PMID: 15314550

3

Lineage and signal strength determine the inhibitory effect of transforming growth factor beta1 (TGF-beta1) on human antigen-specific Th1 and Th2 memory cells.

Holzer U, Rieck M, Buckner JH. Holzer U, et al. Among authors: buckner jh. J Autoimmun. 2006 Jun;26(4):241-51. doi: 10.1016/j.jaut.2006.03.006. Epub 2006 May 30. J Autoimmun. 2006. PMID: 16730947

4

A haplotype-based analysis of the PTPN22 locus in type 1 diabetes.

Onengut-Gumuscu S, Buckner JH, Concannon P. Onengut-Gumuscu S, et al. Among authors: buckner jh. Diabetes. 2006 Oct;55(10):2883-9. doi: 10.2337/db06-0225. Diabetes. 2006. PMID: 17003357

5

Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes.

Rieck M, Arechiga A, Onengut-Gumuscu S, Greenbaum C, Concannon P, Buckner JH. Rieck M, et al. Among authors: buckner jh. J Immunol. 2007 Oct 1;179(7):4704-10. doi: 10.4049/jimmunol.179.7.4704. J Immunol. 2007. PMID: 17878369

6

T cells contain an RNase-insensitive inhibitor of APOBEC3G deaminase activity.

Thielen BK, Klein KC, Walker LW, Rieck M, Buckner JH, Tomblingson GW, Lingappa JR. Thielen BK, et al. Among authors: buckner jh. PLoS Pathog. 2007 Sep 21;3(9):1320-34. doi: 10.1371/journal.ppat.0030135. PLoS Pathog. 2007. PMID: 17892323 Free PMC article.

7

Combination of rapamycin and IL-2 increases de novo induction of human CD4(+)CD25(+)FOXP3(+) T cells.

Long SA, Buckner JH. Long SA, et al. Among authors: buckner jh. J Autoimmun. 2008 Jun;30(4):293-302. doi: 10.1016/j.jaut.2007.12.012. Epub 2008 Mar 3. J Autoimmun. 2008. PMID: 18313267 Free PMC article.

8

The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells.

Schneider A, Rieck M, Sanda S, Pihoker C, Greenbaum C, Buckner JH. Schneider A, et al. Among authors: buckner jh. J Immunol. 2008 Nov 15;181(10):7350-5. doi: 10.4049/jimmunol.181.10.7350. J Immunol. 2008. PMID: 18981158 Free PMC article.

9

Functional islet-specific Treg can be generated from CD4+CD25- T cells of healthy and type 1 diabetic subjects.

Long SA, Walker MR, Rieck M, James E, Kwok WW, Sanda S, Pihoker C, Greenbaum C, Nepom GT, Buckner JH. Long SA, et al. Among authors: buckner jh. Eur J Immunol. 2009 Feb;39(2):612-20. doi: 10.1002/eji.200838819. Eur J Immunol. 2009. PMID: 19180473 Free PMC article.

10

CD44 costimulation promotes FoxP3+ regulatory T cell persistence and function via production of IL-2, IL-10, and TGF-beta.

Bollyky PL, Falk BA, Long SA, Preisinger A, Braun KR, Wu RP, Evanko SP, Buckner JH, Wight TN, Nepom GT. Bollyky PL, et al. Among authors: buckner jh. J Immunol. 2009 Aug 15;183(4):2232-41. doi: 10.4049/jimmunol.0900191. Epub 2009 Jul 27. J Immunol. 2009. PMID: 19635906 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

203 results

Search Page

Filters